Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Collagen IV (alpha3-alpha4) nephropathy].

R Torra1, B Tazón, E Ars

  • 1Servicio de Nefrología, Fundació Puigvert, Cartagena, 340-350 08025, Barcelona.

Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|July 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study.

BMC gastroenterology·2022
Same author

Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement.

Clinical rheumatology·2018
Same author

Early Macrophage Infiltration and Sustained Inflammation in Kidneys From Deceased Donors Are Associated With Long-Term Renal Function.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.

Expert opinion on pharmacotherapy·2016
Same author

Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.

Expert opinion on pharmacotherapy·2016
Same author

PrEFiNe Plan: Strategic plan for Fabry diseases in Nephrology.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2016
Same journal

[Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2024
Same journal

[Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?]

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

[Tixagevimab-cilgavimab as pre-exposure prophylactic treatment against SARS-CoV-2 in kidney transplantation patients].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

[Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: Renal replacement therapy and mortality. FRA-COVID SEN Registry Data].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

Acute interstitial nephritis following COVID-19 vaccination.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2022
See all related articles

Collagen type IV gene mutations cause kidney disease, ranging from mild hematuria to renal failure. These conditions are now unified as "collagen type IV nephropathy" for better diagnosis and management.

Area of Science:

  • Genetics
  • Nephrology
  • Molecular Biology

Context:

  • Mutations in COL4A3, COL4A4, and COL4A5 genes impact the glomerular basement membrane (GBM).
  • This leads to diverse renal manifestations, including isolated hematuria and severe renal failure.
  • Traditionally viewed as distinct disorders like Alport syndrome and familial benign hematuria.

Purpose:

  • To reclassify diverse collagen type IV-related nephropathies under a single umbrella term.
  • To integrate knowledge of the molecular basis driving clinical heterogeneity.
  • To improve diagnostic, prognostic, and management strategies.

Summary:

  • Recent evidence links COL4A3, COL4A4, and COL4A5 gene mutations to various kidney disorders.
  • These mutations affect the GBM, causing a spectrum of nephropathies.

Related Experiment Videos

  • The study proposes unifying these conditions as "collagen type IV nephropathy" based on molecular insights.

    • Impact:

    • This unification has significant implications for clinical practice.
    • It facilitates more accurate diagnosis and prognosis.
    • It enables optimized patient management strategies for collagen type IV nephropathy.